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1. Introduction 
Coordination compounds of some transition 
metals have been shown to possess antimicrobial 
properties. Since the early results on the activity of 
Fe(H) and Ru(I1) complexes with 1, lo-phenanthro- 
line, reviewed by Shulman and Dwyer [ I], the 
silver complexes of sulphadiazine (see ref. [2]) and 
uracil [3] have been reported to have antibacterial 
effects on Pseudomonas aeruginosa. More recently, 
the phenanthroline complexes of Cu(II), Cd(II), 
Zn(II), Mn(II), Fe(B), Co(II), Ni(II), Ru(I1) have 
been reported to have lethal action on Candida 
albicnns, and to induce the formation of miniature- 
colonies in C. albicans and Staphylococcus aureus 
[4]. For what concerns the noble metals, the anti- 
bacterial effects of Rh(II1) [5] and Pt(IV) and (II) 
[6] have been described. In particular, cis-Pt(II)C12 - 
(NH& and related compounds appear to be of wide 
interest, since these planar molecules have been sub- 
sequently shown to possess anumber of biological 
activities. Noteworthy are their powerful antit-umour 
effects in animal models, and encouraging are the 
results obtained in preliminary clinical trials [7]. 
These properties of platinum drugs have led us to 
examine the biological activities of molecules with a 
similar planar structure, but containing rhodium 
instead of platinum. The compounds are: 
[Rh(I)bipyCOD]+Cl- and [Rh(I)phenCOD]+Cl- 
bipy = 2,2’-bipyridine phen = 1, IO-phenanthroline 
COD = cis-cis- 1,5-cyclooctadiene 
In this communication we report on the effects of 
these complexes on growth and metabolism of 
bacteria. The antineoplastic activity of such com- 
plexes will be reported elsewhere. 
2. Materials and methods 
The effects on bacterial growth were determined 
by adding the substance to be tested to cultures of 
different strains of E. coli or of Staph. aureus at the 
beginning of the exponential growth. The inhibitory 
effects were measured spectrophotometrically at a 
time corresponding to the end of the exponential 
growth in control cultures. 
The effects on macromolecular syntheses were 
determined by adding 5 ,uCi (2.5 l.(g) of 3 H-methyl- 
thymidine, 5 E.tC!i (3 pg) of [3 H] uridine or 5 @i 
(13 c(p) of [3H]leucine (Radiochemical Center, 
Amersham, England) per ml of acetively growing cul- 
tures in MM, pretreated for 10 min with the Rh(I) 
complex. The acid insoluble radioactivity was 
measured on 50 ~1 samples, which were pipetted on 
Whatman 3MM chromatographic paper disks, subse- 
quently processed according to the methods of 
Bollum [8]. 
The water-n-octanol partition coefficients 
P = CH?O /Co, were determined essentially as des- 
cribed by Fujita et al. [9]. Typically, a sample giving 
an extinction of about 0.5 in water, was partitioned 
with an equal volume of n-octanol. The extinction 
of the two phases was determined spectrophoto- 
metrically; adherence to Beer’s law was checked in 
both solvents. 
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Table 1 
Effects of rhodium complexes and their free ligands on bacterial growth 
E. coli E. coli E. coli E. coli E. coli E. coli S. aureus 
Bacterial strain w3110 pol A- HfrH K12 h- HfrH K12 h- Oxford 
Medium MM MM MM MM BHI BHI BHI log. P 
WY 126.8 110.2 168.6 364.7 318.5 640 640 -1.168 
Rh-bipy 13.1 11.5 18.3 2.5 -7.5 248 > 248 36.4 -0.120 
Phen 19.4 21.0 21.1 13.7 83.4 14.5 68.9 -1.034 
Rh-phen 25.4 20.8 24.7 4.54 110.3 80.9 11.7 -0.0267 
Each value is the DI,, (PM) calculated by the method of Spermann and Karber on the per cent inhibition figures obtained as des- 
cribed in the experimental section. Bacteria were grown as indicated in minimal medium (MM), supplemented for W31 i0 and 
polA- strains with 0.38 mM thymine [19], or in brain heart infusion DIFCO (BHI). 
3. Results and discussion 
Data reported in table 1 show that the bipyridine 
complex has an inhibitory activity on bacterial 
growth in MM much greater than that of its free 
ligand, with a DISa ranging from 2.5 to about 18 PM. 
The sensitivity of Staph. aureus in BHI to Rh-bipy 
allow to rule out the possibility that the reduced 
sensitivity of E. coli HfrH and K12 h- when tested 
in BHI is due to inactivation of the rhodium complex 
by medium components. 
On the contrary, the phenanthroline complex has 
an inhibitory capacity comparable to that of the free 
phenanthroline, except on Staph. aureus, where the 
complex is about six times more active on a molar 
basis. These results could be explained by considering: 
i) the liposolubility of these substances, expressed 
as the log p, which is much greater for phenanthroline 
than for the related complex, and ii) the differences 
in surface structure between Gram-positive and 
Gram-negative microorganisms. Even more important 
is the fact that phenanthroline, other than being con- 
siderably liposoluble, has been reported to have 
bactericidal effects on Bacillus stearothermophillus, 
attributed to its iron chelating properties [lo]. 
No significant differential sensitivity to these drugs 
is shown by E. cob polA_. This bacterial strain, 
lacking the DNA repairing capacity [l 11, has been 
shown to be much more sensitive than pol A+ to a 
large number of agents known to alter cellular DNA 
[12], and has been used in order to investigate the 
occurence of interactions between Rh(1) compounds 
and bacterial DNA. 
14 
As reported in fig. 1, at 1 w/ml Rh-bipy causes 
a selective inhibition of nucleic acids synthesis, 
leaving substantially unaffected the protein synthesis. 
It is interesting to compare these data with those 
already reported for platinum compounds. These 
substances have different effects on bacterial and 
tumour growth, depending on their structure. While 
charged molecules are bactericidal at concentrations 
similar to those reported above for rhodium com- 
plexes [6], they have little or no effects on tumours 
[ 131. On the contrary, the neutral species, which at 
the same concentrations cause only an elongation of 
the bacterial cells [6], have powerful antineoplastic 
properties [7], and induce prophages in lysogenic 
strains [ 141. 
The charged Rh(1) complexes are similarly bac- 
tericidal and do not induce phage production, as 
shown by the absence of a greater sensitivity of HfrH 
strain to these substances. A pulse treatment with 
Rh-bipy for 2, 5, or 10 min, followed by titration 
of the phagcs produced, also showed no effect. 
A partial elongation (2-3x) in about 80% of the cells 
is observed only with Rh-bipy at 3 @r/ml. 
As for the possible mechanism of action, the 
selective inhibition of nucleic acids synthesis caused 
by Rh-bipy could be attributed to an interaction of 
the complex with the bacterial nucleic acids. Coordi- 
nation with platinum has been reported to occur both 
with purified DNA [ 151 and DNA of mammalian 
cells cultivated in vitro in the presence of platinum 
drugs [ 161. In the latter case however only DNA 
synthesis was selectively and irreversibly inhibited 
[ 17,181. In view of these considerations it is conse- 
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Fig. 1. Effects of rhodiumbipy on macromolecular syntheses in E. coli K12 A-. The labelled precursors were added 10 mm after 
the addition of the rhodium complex to a final concentration of 0 (n), 1 (m), 3 (o), 10 (0) pg/ml, and the acid insoluble radio- 
activity determined when indicated. 
quently difficult to understand the effects rhodium 
compounds on bacterial macromolecular metabolism, 
and the absence of a differential sensitivity between 
polA_ and polA’ strains, unless interactions more 
complex than coordination of bacterial DNA occur. 
All these data and the preliminary results of 
screening for antineoplastic activity, seem to encour- 
age a deeper examination of the biological activities 
of these and related compounds. 
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